Biomarker: F049-IgE Apple

Overview

F049-IgE Apple measures immunoglobulin E (IgE) antibodies in blood that recognize apple allergens. IgE is involved in immediate-type allergic reactions, and apple-specific IgE indicates sensitization to apple proteins. A high result may support possible apple allergy, while a low or undetectable result makes IgE sensitization less likely but does not independently exclude allergy. The test is clinically useful when interpreted with the patient’s reaction history, examination, and, when necessary, supervised oral food challenge, because specific IgE alone cannot confirm allergy or predict reaction severity.

Clinical Use Cases

Supports evaluation of suspected IgE-mediated allergy to apple.
Assesses sensitization in people with symptoms after eating fresh or processed apple.
Helps evaluate pollen-food allergy syndrome, particularly in people with birch-pollen allergy and oral symptoms after eating apple.
Supports investigation of possible cross-reactivity involving apple allergens such as Mal d 1 and Mal d 3.
Helps guide allergist-supervised decisions about additional testing, dietary avoidance, or oral food challenge.
May be used in clinical research to assess changes in apple-specific IgE during immunotherapy or other interventions.

Specimen Types

Venous blood, typically processed as serum for laboratory allergen-specific IgE testing.
Capillary blood may be used by some testing systems, depending on the laboratory method and collection protocol.

Measurement Methods

In-vitro allergen-specific IgE immunoassay using an apple extract or defined apple allergen preparation.
Fluorescent enzyme immunoassay.
Enzyme-linked immunosorbent assay.
Chemiluminescent immunoassay.
Immunoblotting, primarily for research or allergen-component characterization rather than routine diagnosis.
Skin-prick testing with apple extract is a related in-vivo assessment of sensitization, but it is not the same measurement as serum F049-IgE.
Component-resolved testing may measure IgE to individual apple proteins, including Mal d 1 or Mal d 3, when clinically available.

Test Preparation and Influencing Factors

Fasting is generally not required for a serum-specific IgE blood test.
Do not stop or change prescription or over-the-counter medicines without medical advice. Unlike skin-prick testing, blood-specific IgE testing is generally less affected by antihistamines.
The result should be interpreted with the timing, amount, preparation, and variety of apple consumed and the symptoms that occurred.
Cooking and food processing can alter the allergenicity of some apple proteins, so reactions to raw apple may not predict reactions to cooked apple, and vice versa.
Apple varieties may differ in allergen profiles and allergen content.
Birch-pollen sensitization can contribute to cross-reactive IgE responses, particularly involving Mal d 1, and may be relevant when interpreting oral symptoms after raw apple.
A positive result indicates sensitization and does not by itself establish clinically significant food allergy.
The numerical IgE concentration does not reliably predict the severity of a future reaction.
Testing should be targeted to foods suspected from the clinical history because false-positive results can occur.
A medically supervised oral food challenge may be required when the history and test results do not establish whether apple causes clinical reactions.